Xolair for Severe allergic asthma
Quick answer: Xolair is used for Severe allergic asthma as part of a anti-ige monoclonal antibody treatment regimen. Recombinant humanized IgG1 monoclonal antibody binding free IgE, preventing its interaction with FcεRI receptors on mast cells and basophils The specific dosing for Severe allergic asthma is determined by your prescriber based on individual factors.
Why is Xolair used for Severe allergic asthma?
Xolair belongs to the Anti-IgE monoclonal antibody class. Recombinant humanized IgG1 monoclonal antibody binding free IgE, preventing its interaction with FcεRI receptors on mast cells and basophils This action makes it useful for treating or managing Severe allergic asthma in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Xolair is the right choice for a specific patient depends on the type and severity of Severe allergic asthma, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Severe allergic asthma
Common adult dosing range: 75-600 mg subcutaneously every 2-4 weeks (weight/IgE-based). The actual dose for Severe allergic asthma depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Xolair medicine page.
What to expect
Xolair treatment for Severe allergic asthma typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Severe allergic asthma
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Xolair is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Anti-IgE monoclonal antibody for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Xolair
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Xolair full prescribing information · All Anti-IgE monoclonal antibody alternatives
Frequently asked questions
How effective is Xolair for Severe allergic asthma?
Effectiveness varies by individual response, dose, and severity. Xolair is one of several treatment options for Severe allergic asthma, supported by clinical evidence within the anti-ige monoclonal antibody class. Discuss expected response with your prescriber.
How long do I need to take Xolair for Severe allergic asthma?
Treatment duration depends on the nature of Severe allergic asthma — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Xolair when used for Severe allergic asthma?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Xolair for Severe allergic asthma?
Yes. Multiple medicines and non-drug options exist for Severe allergic asthma. Alternatives within the anti-ige monoclonal antibody class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.